Bicara Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

SCHEDULE 13G/AOct. 7, 2026, 2:57 p.m. ETView on SEC.gov
4Sept. 10, 2026, 4:23 p.m. ETView on SEC.gov
8-KAug. 25, 2026, 4:58 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Financial statements and exhibits
4Aug. 14, 2026, 4:54 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 13, 2026, 12:42 p.m. ETView on SEC.gov
4Aug. 12, 2026, 4:19 p.m. ETView on SEC.gov
4Aug. 12, 2026, 4:19 p.m. ETView on SEC.gov
4Aug. 12, 2026, 4:19 p.m. ETView on SEC.gov
10-QAug. 11, 2026, 4:46 p.m. ETView on SEC.gov
8-KAug. 11, 2026, 7:36 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4July 29, 2026, 4:18 p.m. ETView on SEC.gov
4July 29, 2026, 4:18 p.m. ETView on SEC.gov
8-KJuly 28, 2026, 8:35 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
SCHEDULE 13GJuly 27, 2026, 4:25 p.m. ETView on SEC.gov